Industry Focus

Despite significant risks, Berkshire Hathaway’s become Teva Pharmaceutical’s 9th biggest investor. Also, what gives with Rite Aid’s convoluted merger plans?

Direct download: 20180221_IF_Healthcare.mp3
Category:Podcast -- posted at: 3:30pm EST